Investors pulled over $1bn from a US tech ETF last week following the sector’s recent underperformance since companies successfully tested for a coronavirus vaccine.
According to data from Ultumus, the $743m Xtrackers MSCI USA Information Technology UCITS ETF saw a huge $1bn outflows in the week to 4 December, the second-highest across all ETFs listed in Europe.
The tech sector has significantly underperformed since Pfizer successfully tested for a vaccine causing a rally in pro-cyclical stocks.
Highlighting this, the Russell 1000 Value index outperformed the Russell 1000 Growth index by 6% on 10 November, the highest daily excess return over the past decade.
XUTC has returned 3.8% over the past month versus 37.2% for the iShares S&P 500 Energy Sector UCITS ETF (IUES), as at 7 December.
However, with 22.2% exposure to Apple and 16.4% to Microsoft, XUTC has delivered returns of 41.8% so far this year despite the recent underperformance.
The recent outflows could represent investors cashing in on these stellar returns this year with US tech driving the outperformance of the S&P 500.
Despite the cyclical rally, Paul Craig, portfolio manager at Quilter Cheviot, said tech companies could be set to be the long-term winners of the coronavirus volatility.
“On the winning side are tech-based companies that have benefited from the changes in living and working patterns brought about by lockdown,” Craig continued. “These changes have provided a once in a generation boost for platforms, the cloud, automation, online facilitation, digital payments and robotics.
“While these sectors have suffered a little from the ‘value’ renaissance of late, they are still most likely to benefit over the long-term.”
Elsewhere, the Xtrackers MSCI USA Health Care UCITS ETF suffered $647m outflows, the third-most across European ETFs.
Heading into 2021, the BlackRock Investment Institute said it prefers a barbell approach of combining tech and healthcare as a result of the structural shift from the coronavirus pandemic along with certain cyclical exposures.
“The US and Europe face challenges in the very near term: A resurgence of virus cases may result in outright economic contraction.
“Yet positive vaccine news is a game changer in that we now know we are building a bridge to somewhere, providing clarity for policymakers, companies and markets about getting to a post-COVID-19 stage.
“We like tech and healthcare due to the pandemic’s transformative shifts.”
Have you seen our new ETF data tool?
Just click on any of the ETF links in the article above and you will get access to a whole host of data including:
- Historical Performance
- Sector and country weights
- Portfolio analysis
- Similar ETFs